// App-Quantinova.ai

: Effect of triple therapy with extra-fine BDP/FF/GB pMDI during seasonal peaks of asthma exacerbations. A post-hoc analysis of the TRIMARAN and TRIGGER studies

Researchers

Presenter

  • Alberto Papi

Principal Investigators

  • Dave Singh

  • Christian J Virchow

  • Maxim Kots

  • Andrea Vele

  • George Georges

  • Giorgio W. Canonica

Medical Centers

  • University of Ferrara, Ferrara, Italy

  • University of Manchester, Manchester, United Kingdom

  • Department of Pneumology/Intensive Care Medicine, University of Rostock, Rostock, Germany.

  • Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy.

  • Humanitas University and Humanitas Research Hospital, Milano, Italy

Locations

  • Italy

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Salbutamol

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

  • Parallel Group

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved